tiprankstipranks
Trending News
More News >
Mixed Performance and Market Challenges Lead to Hold Rating for Bausch + Lomb Corporation
PremiumRatingsMixed Performance and Market Challenges Lead to Hold Rating for Bausch + Lomb Corporation
20d ago
Bausch + Lomb price target lowered to $16 from $19 at Barclays
Premium
The Fly
Bausch + Lomb price target lowered to $16 from $19 at Barclays
21d ago
Bausch + Lomb Expands Eye Care Range with New Blink Eye Drops
Premium
Company Announcements
Bausch + Lomb Expands Eye Care Range with New Blink Eye Drops
26d ago
Bausch + Lomb Introduces Zenlens CHROMA HOA Lenses in U.S.
PremiumCompany AnnouncementsBausch + Lomb Introduces Zenlens CHROMA HOA Lenses in U.S.
2M ago
Bausch + Lomb’s LuxLife Intraocular Lens Gains European CE Mark Approval
Premium
Company Announcements
Bausch + Lomb’s LuxLife Intraocular Lens Gains European CE Mark Approval
2M ago
Bausch + Lomb announces CE Mark approval for LuxLife
Premium
The Fly
Bausch + Lomb announces CE Mark approval for LuxLife
2M ago
Bausch + Lomb price target lowered to $11 from $17 at BofA
PremiumThe FlyBausch + Lomb price target lowered to $11 from $17 at BofA
2M ago
Bausch + Lomb price target lowered to $13 from $14 at Citi
Premium
The Fly
Bausch + Lomb price target lowered to $13 from $14 at Citi
2M ago
Bausch + Lomb Corporation: Sell Rating Amid Financial Pressures and Uncertain Tariff Impacts
Premium
Ratings
Bausch + Lomb Corporation: Sell Rating Amid Financial Pressures and Uncertain Tariff Impacts
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100